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NF-KB and C/EBP represent distinct families of transcription factors that target unique DNA enhancer
elements. The heterodimeric NF-KB complex is composed of two subunits, a 50- and a 65-kDa protein. All
members of the NF-cB family, including the product of the proto-oncogene c-rel, are characterized by their
highly homologous -300-amino-acid N-terminal region. This Rel homology domain mediates DNA binding,
dimerization, and nuclear targeting of these proteins. C/EBP contains the bZIP region, which is characterized
by two motifs in the C-terminal half of the protein: a basic region involved in DNA binding and a leucine zipper
motif involved in dimerization. The C/EBP family consists of several related proteins, C/EBPa, C/EBP3,
C/EBP-y, and C/EBP8, that form homodimers and that form heterodimers with each other. We now
demonstrate the unexpected cross-coupling of members of the NF-cB family with three members of the C/EBP
family. NF-cB p65, p50, and Rel functionally synergize with C/EBPa, C/EBPf3, and C/EBP8. This
cross-coupling results in the inhibition of promoters with KB enhancer motifs and in the synergistic stimulation
of promoters with C/EBP binding sites. These studies demonstrate that NF-KB augments gene expression
mediated by a multimerized c-fos serum response element in the presence of C/EBP. We show a direct physical
association of the bZIP region ofC/EBP with the Rel homology domain of NF-KB. The cross-coupling of NF-cB
with C/EBP highlights a mechanism of gene regulation involving an interaction between distinct transcription
factor families.
Transcriptional regulation of gene expression is controlled
by factors that bind to specific DNA sequences. Many of
these factors can be classified into distinct families based on
common structural motifs. These families include the homeo-
domain family (30), the zinc finger proteins (26, 46), the
leucine zipper family (49, 84), and the helix-loop-helix family
(59, 60). Many of these transcription factors bind to their
cognate DNA motifs as homodimers and, moreover, there
are multiple examples of heterodimer formation within the
same family of transcription factors. However, there is
growing evidence that these dimerization motifs are also
involved in interactions between transcription factors from
different families. Examples are the interaction of the Jun
leucine zipper region with the helix-loop-helix motif of
MyoD (12) or with the DNA binding and ligand binding
regions of the glucocorticoid receptor (24, 42, 74, 87). This
cross-coupling between different families might lead to the
formation of novel transcription factor complexes displaying
altered biological activities.
The transcription factor NF-KB binds to KB enhancer
motifs found in a variety of genes in response to various
signals (5 and references therein, 35, 51). NF-KB DNA
binding activity typically involves two subunits, a 50-kDa
protein (17, 31, 45) and a 65-kDa protein (63, 72). NF-KB p50
and NF-KB p65 share a highly homologous 300-residue
N-terminal region. This region is also found in the products
of the proto-oncogene c-rel and of the dorsal maternal effect
gene of Drosophila melanogaster (16, 31, 32, 38, 80). The
Rel homology region of these proteins mediates DNA bind-
ing, dimerization, nuclear targeting, and interactions with
IKB (9, 11, 17, 31, 33, 45, 63, 72).
The C/EBP family of transcription factors belongs, to-
* Corresponding author.
gether with AP-1 and ATF/CREB, to a class ofDNA binding
proteins named bZIP proteins (84). These proteins are char-
acterized by their leucine zipper structure and the adjacent
DNA binding basic region, both located in the C-terminal
half of the respective proteins. The originally characterized
CCAAT/enhancer-binding protein CIEBP (41) is now named
C/EBPa. C/EBPI (20) is the new term for LAP (23), IL6-
DBP (67), CRP2 (86), AGP/EBP (21), and NF-IL6 (2).
C/EBP-y replaces the old name Ig/EBP-1 (71). C/EBPa,
C/EBP,3, C/EBP-y, and C/EBPb (20) form homodimers and
heterodimers with each other in vitro and bind with a similar
affinity to various C/EBP binding sites (20, 48). All members
of the C/EBP family are encoded by different genes, and the
amino acid sequences of the N-terminal two-thirds of these
proteins are not related. C/EBPot expression is tissue re-
stricted, with the highest expression occurring in liver,
adipose, and intestinal tissue (14). C/EBPa is an activator of
specific gene expression (22, 28, 29, 43, 65, 81). Further-
more, C/EBPa plays a general role in cellular growth inhi-
bition (82) and has a hypothetical responsiveness to hor-
mones that modulate energy balance (54). The c-fos serum
response element (SRE) contains overlapping binding sites
for the serum response factor and C/EBPP (56). Cyclic AMP
(cAMP) stimulates phosphorylation and translocation of
C/EBPI to the nucleus in PC12 cells. These events induce
C/EBP,B binding to the SRE and activate c-fos expression
(55). Interestingly, several promoters of immune or acute-
phase response genes, such as the interleukin-6 (IL-6) gene,
the IL-8 gene, and the angiotensinogen gene, have adjacent
or overlapping binding sites for C/EBP and NF-KB (19, 40,
58).
In this study, we show that members of the NF-KB/Rel
family can interact with three members of the C/EBP family.
This cross-coupling results in the inhibition of promoters
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with KB enhancer motifs and the synergistic stimulation of
promoters with C/EBP binding sites. Specifically, NF-KB
augments gene expression mediated by a multimerized c-fos
SRE in the presence of C/EBP. A direct physical interaction
between the bZIP region of C/EBP and the Rel homology
domain of NF-KB is demonstrated.
MATERIALS AND METHODS
Plasmid constructs. The KB-TATA-CAT and SRE-TATA-
CAT reporter plasmids have been described elsewhere (42,
79). The C/EBP-TATA-CAT reporter was generated by
cloning a single copy of an oligonucleotide with a C/EBP
binding site derived from the c-fos SRE (5' AGCTTGATT
AGGACATCG 3') (binding site printed in boldface type) into
HindIII-BamHI-cut TATA-CAT. The CRE-TK-CAT re-
porter contains a single copy of a CREB binding site (5'
AGCT'lGTGACGTCACCCG 3') (binding site printed in
boldface type) cloned into HindIII-BamHI-cut pBLCAT4
(79). The Myb-TK-CAT reporter contains five copies of a
Myb binding site cloned in front of the herpes simplex virus
thymidine kinase promoter (46a). The pCMV4T plasmid was
derived from pCMV4 (3) by inserting an oligonucleotide with
stop codons in all three reading frames into the SmaI site.
The pCMV4T-p65 and pCMV4T-p50 plasmids contain
cDNAs encoding human NF-KB p65 (72) and NF-KB p50
(amino acids 1 to 462) (45), respectively. Plasmid pCMV4T-
p65mLZ was constructed by polymerase chain reaction-
assisted site-directed mutagenesis of NF-KB p65, resulting in
the change of amino acids 436-LSEALLQLQFDDEDL-450
to 436-ASEAALQAQFDDEDA-450 (underlining highlights
changes). Plasmid pCMV4T-p65A10 encodes an alterna-
tively spliced form of NF-KB p65 with an internal deletion of
amino acid residues 222 to 231 (61, 73). Plasmid pCMV4T-
p65Eco contains a cDNA encoding the Rel homology do-
main of NF-KB p65 (amino acids 1 to 282). Expression
vectors pCMV4T-vRel and pCMV4T-hcRel are as described
previously (9). Plasmid pCMV4T-rC/EBP3 contains a cDNA
encoding rat C/EBPP (67) cloned into pCMV4T. Cytomega-
lovirus (CMV) enhancer-driven expression vectors for hu-
man C/EBPa, C/EBPP, and C/EBPb were a gift of Steven L.
McKnight. The mouse c-Jun, human c-Fos, and human
CREB pCMV4T expression vectors contain full-length cod-
ing sequences of the corresponding T7 polymerase-driven
vectors (13, 69, 70) cloned downstream of the CMV imme-
diate-early-region promoter. The wild-type Myb expression
vector (pRmb3SVneo) and the corresponding frameshift
control pJTmyb-fs have been described elsewhere (25). The
bacterial FLAG-heart muscle kinase (HMK) fusion protein
expression vectors were constructed by cloning the cDNAs
for NF-KB p65, NF-KB p50 (amino acids 1 to 462), and rat
C/EBPP as polymerase chain reaction-amplified fragments
into the EcoRI site of the T7 polymerase-driven FLAG-
HMK vector (15). The bacterial glutathione S-transferase
(GST) fusion protein expression vectors were constructed
by cloning the cDNAs for rat C/EBPP and the bZIP trunca-
tion of rat C/EBPP (C/EBPPbZIP; encoding amino acids 187
to 297) as polymerase chain reaction-amplified fragments in
frame into the EcoRI site of pGEX-1N (Amrad). Expression
vectors for in vitro transcription were generated by cloning
the cDNAs for NF-KB p65, NF-KB p65A10, and NF-KB p50
(amino acids 1 to 462) into pGEM4 (Promega). In vitro-
translated proteins NF-KB p65Eco (amino acids 1 to 282) and
NF-KB p65Bgl (amino acids 1 to 194) were generated by
runoff transcription terminated at internal EcoRI and BglII
sites, respectively.
Transfection of cells and analysis of CAT activity. All cell
lines were cultured in Iscove's Dulbecco modified Eagle
medium supplemented with 7.5% fetal calf serum and anti-
biotics. Mouse F9 embryonal carcinoma cells were tran-
siently transfected by the calcium phosphate method (34).
Monkey COS cells were transiently transfected with plasmid
DNA by the DEAE-dextran method (44). Chloramphenicol
acetyltransferase (CAT) enzymatic activity was assayed as
previously described (62) and normalized for protein recov-
ery (18).
Bacterial expression of proteins. Human C/EBPabZIP,
C/EBPPbZIP, and C/EBP&bZIP proteins expressed in bac-
teria (20, 78) were a generous gift of Steven L. McKnight.
The FLAG-HMK fusion proteins were expressed in Esche-
richia coli BL21 (LysS). The GST fusion proteins were
expressed in E. coli JM109. Bacteria were grown overnight,
diluted 1:10 and, after another hour of growth, stimulated
with 0.4 mM isopropyl-3-D-thiogalactopyranoside (IPTG)
for 3 h at 32°C. Bacteria were then harvested, resuspended in
a 0.1 volume of phosphate-buffered saline (PBS), and soni-
cated for 1 min in PBS, and the extracts were cleared by
centrifugation.
Purification and 32p labeling of proteins. Cytosolic NF-KB
from HeLa cells was purified as previously described (9).
Bacterially expressed human C/EBP proteins containing
only the bZIP domain were purified by column chromato-
graphic techniques as described previously (20, 78). Bacte-
rially expressed FLAG-HMK fusion proteins were purified
by low-pH elution from an M2 anti-FLAG antibody column
(IBI-Kodak, New Haven, Conn.) in accordance with the
manufacturer's instructions. FLAG-HMK fusion proteins
were labeled in vitro with [_y-32P]ATP by use of HMK
(Sigma) in buffer containing 20 mM Tris (pH 7.6), 100 mM
NaCl, 12 mM MgCl2, and 1 mM dithiothreitol for 60 min at
37°C (15). Whole-cell extracts from COS cells were prepared
by a method used to prepare CAT assay extracts (4) 3 days
posttransfection.
EMSA. Electrophoretic mobility shift assays (EMSA)
were performed as previously described (79). The binding
buffer contained 12 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES)-NaOH (pH 7.9), 4 mM Tris
(pH 7.9), 60 mM KCl, 5 mM MgCl2, 0.6 mM EDTA, 12%
glycerol, and 5 mM dithiothreitol. The human immunodefi-
ciency virus type 1 (HIV-1) KB probe was as previously
described (79). The C/EBP binding site found as a core
sequence within the c-fos SRE was created by annealing the
oligonucleotides 5' AGC1TGATTAGGACATCG 3' and 5'
GATCCGATGTCCTAATCA 3' (binding site printed in bold-
face type).
Coimmunoprecipitation. For coimmunoprecipitation anal-
yses, 0.6 ,ul of 32P-labeled FLAG-HMK fusion protein was
combined with 5 p,l of unlabeled bacterial protein in EMSA
binding buffer. After 15 min of incubation at room tempera-
ture (RT), the chemical cross-linker dithio-bis(succinimidyl-
propionate) (DSP) (Pierce) was added at a final concentra-
tion of 2 mM, and the mixture was incubated for 30 min at
RT. The cross-linking reaction was squelched by the addi-
tion of 100 mM ethanolamine. After the volume was in-
creased with RIPA buffer, normal rabbit serum and protein
A-Sepharose were added, and the mixture was incubated for
1 h at 4°C. The immunoreaction was then cleared, specific
antibody and protein A-Sepharose were added, and the
mixture was incubated for 2 h at 4°C. After the immunocom-
plexes were washed, the cross-linked complexes were re-
duced with Laemmli sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE) loading buffer (47) contain-
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FIG. 1. Cross-coupling of NF-KB p65 with C/EBPI. Mouse F9 embryonal carcinoma cells were transiently cotransfected with 8 p,g of the
indicated CAT reporter plasmids (KB-TATA-CAT, containing one copy of the duplicated HIV-1 KB enhancer motif from the HIV-1 long
terminal repeat [positions -105 to -79] linked to the TATA box of the X. laevis albumin gene; SRE-TATA-CAT, containing four copies of
the SRE of the human c-fos promoter [-320 to -2991; and C/EBP-TATA-CAT, containing one copy of a C/EBP binding site and 0.1 p,g of
pCMV4T-p65 (A), 1 p1g of pCMV4T-rC/EBP, (B and C), and increasing amounts (0 to 6 ,g) of pCMV4T-rC/EBP,B (A) or pCMV4T-p65 (B
and C). The total amount of transfected DNA was kept constant by the addition of the parental pCMV4T vector. At 6 h after transfection,
CAT activity was determined. The mean levels ofCAT activity determined in at least three independent experiments are presented as the fold
induction relative to the activity obtained with transfected pCMV4T alone. The standard errors were always less than 20% of the means.
ing 15% ,3-mercaptoethanol, boiled, and subjected to SDS-
PAGE.
GST fusion protein interaction assay. Glutathione-
Sepharose 4B beads (Pharmacia) were equilibrated in
PBS-1% Triton X-100 and then mixed with 20 volumes of
bacterial GST fusion proteins on a rotary shaker for 20 min
at RT. The beads were washed three times with PBS-1%
Triton X-100 and then equilibrated in 20 mM HEPES-NaOH
(pH 7.9)-25 mM NaCl-2.5 mM MgCl2-0.1 mM EDTA-
0.05% Nonidet P-40-1% Triton X-100 (LSBT). Five micro-
liters of a 1:1 bead slurry in PBS was combined with 5 ,ul of
a 35S-labeled reticulocyte lysate in a final volume of 200 ,ul of
LSBT-1 mM dithiothreitol-1 mM phenylmethylsulfonyl flu-
oride on a rotary shaker for 60 min at RT. The beads were
then washed four times with LSBT and once with 50 mM
Tris (pH 6.8). The bound proteins were eluted by boiling in
Laemmli SDS-PAGE loading buffer (47) and subjected to
SDS-PAGE.
Western blot (immunoblot) analysis. Nuclear extracts from
-1 x 106 COS cells prepared 3 days after transfection as
described previously (79) were fractionated by SDS-PAGE,
blotted onto a nitrocellulose membrane, and immunostained
by use of an Amersham enhanced chemiluminescence (ECL)
kit in accordance with the manufacturer's instructions.
RESULTS
NF-KB functionally acts in synergy with C/EBP-related
proteins. NF-KB activity is increased in response to IL-1
(64), and C/EBPf is activated by IL-6 (66). Interestingly,
synergy between IL-1 and IL-6 in several physiological
responses, including the acute-phase response, in T-cell
activation, and in immunoglobulin secretion has been re-
ported (1, 37, 83). To test for possible cross-coupling be-
tween the NF-KB and C/EBP families of transcription fac-
tors, we performed transfection experiments with mouse F9
embryonal carcinoma cells. F9 cells were selected because
of their exceedingly low levels of endogenous nuclear
NF-KB (39, 78a). F9 cells were transfected with a CAT
reporter plasmid composed of the duplicated HIV-1 KB
enhancer motif linked to the TATA box of the Xenopus
laevis albumin gene (KB-TATA-CAT). This KB enhancer
motif is sufficient to mediate activation by various members
of the NF-KB transcription factor family (8, 78a). Unexpect-
edly, cotransfection of a rat C/EBPP expression vector
strongly reduced the induction of KB-TATA-CAT by NF-KB
p65 in a dose-dependent manner (Fig. 1A). Therefore, we
were interested in whether C/EBPP functions as a positive
regulator of gene expression in F9 cells when tested on
reporter plasmids containing C/EBP binding sites. SRE-
TATA-CAT is a reporter plasmid in which the KB enhancer
motifs are replaced with four repeats of the c-fos SRE that
contains in its core a C/EBP binding site (55, 56). Expression
of rat C/EBP,B in F9 cells caused dose-dependent activation
of this reporter plasmid (data not shown and Fig. 1B). To
analyze whether a single C/EBP binding site is sufficient to
mediate the stimulation of CAT activity by C/EBP, we
transfected F9 cells with C/EBP-TATA-CAT, a reporter
plasmid with one copy of a core C/EBP binding site. As
expected, cotransfection of a rat C/EBPt3 expression vector
led to the strong activation of this reporter plasmid in a
dose-dependent manner (data not shown). These results also
indicate that the inhibitory effect of C/EBPI on KB-TATA-
CAT gene transcription was dependent on the KB enhancer
motifs. We then transfected a combination of NF-KB p65 and
rat C/EBPPI and observed strong synergistic stimulation of
SRE-TATA-CAT (Fig. 1B), while NF-KB p65 by itself was
unable to affect the expression of SRE-TATA-CAT (data not
shown). Similar results were obtained when the C/EBP-
TATA-CAT reporter plasmid with a single C/EBP binding
site was used (Fig. 1C). To detect possible differences in
KB-TATA-CAT
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FIG. 2. Cross-coupling of NF-KB p65 with C/EBP-related proteins. (A) Mouse F9 embryonal carcinoma cells were transiently
cotransfected with 8 ,ug of CAT reporter plasmid KB-TATA-CAT (containing one copy of the duplicated HIV-1 KB enhancer motif from the
HIV-1 long terminal repeat [positions -105 to -79] linked to the TATA box of the X. Iaevis albumin gene), 0.1 p,g of pCMV4T-p65, and 6
pg of pCMV4T or CMV expression vectors for rat C/EBP3 or human C/EBPa, C/EBPI, and C/EBP8. CAT activity is presented as percent
inhibition relative to 100% activity obtained with transfected pCMV4T alone. (B) Mouse F9 embryonal carcinoma cells were transiently
cotransfected with 8 p,g of CAT reporter plasmid SRE-TATA-CAT (containing four copies of the SRE of the human c-fos promoter [-320
to -299]) and 1 pg of CMV expression vectors for rat C/EBP,B or human C/EBPa, C/EBPP, and C/EBPB in the presence or absence of 3 pg
of pCMV4T-p65. The total amount of transfected DNA was kept constant by the addition of the parental pCMV4T vector. At 6 h after
transfection, CAT activity was determined. CAT activity is presented as the fold induction relative to the activity obtained with transfected
pCMV4T alone. (C) Monkey COS cells were transiently transfected with 12 1.g of pCMV4T (lanes 1, 6, 9, and 12); a combination of 400 ng
of pCMV4T-p65 and 12 Fg of pCMV4T, pCMV-C/EBPx, pCMV-C/EBPO, or pCMV-C/EBPB (lanes 2 to 5); a combination of 4 pg of
pCMV-C/EBPa and 12 pg of pCMV4T or pCMV4T-p65 (lanes 7 and 8); a combination of 4 pg of pCMV-C/EBP3 and 12 pg of pCMV4T or
pCMV4T-p65 (lanes 10 and 11); or a combination of 4 ,ug of pCMV-C/EBPB and 12 p,g of pCMV4T or pCMV4T-p65 (lanes 13 and 14). The
SDS-PAGE-fractionated and blotted nuclear proteins prepared from cells 3 days after transfection were immunostained with antibodies
specific for NF-KB p65 (lanes 1 to 5), C/EBPa (lanes 6 to 8), C/EBP, (lanes 9 to 11), and C/EBPB (lanes 12 to 14). The arrowheads indicate
the positions of the expressed proteins.
transcriptional activity among three members of the C/EBP
family, we compared the effect of rat C/EBP,B and human
C/EBPa, C/EBPI, and C/EBPb on the induction of KB-
TATA-CAT by NF-KB p65 in F9 cells. All three isoforms of
human C/EBP were able to strongly inhibit a KB enhancer-
dependent promoter (Fig. 2A). Similarly, NF-KB p65 was
able to synergistically activate SRE-TATA-CAT in the pres-
ence of human C/EBPa, C/EBPj, or C/EBPb (Fig. 2B).
Western blot analyses of nuclear extracts from cells trans-
fected with combinations of NF-KB p65 and C/EBP showed
that the decreased activation of KB-TATA-CAT by NF-KB
p65 in the presence of cotransfected C/EBP expression
vectors was not the result of an inhibition of NF-KB p65
expression. Vice versa, the expression of C/EBP family
members was not increased by the cotransfected NF-KB p65
expression vector (Fig. 2C).
Several members of the NF-KB/Rel family cross-couple with
C/EBP,B. The functional interaction between the NF-KB/Rel
and C/EBP transcription factor families was further con-
firmed by cotransfection of plasmid KB-TATA-CAT with
expression vectors for different members of the NF-KB
family (Table 1) in the absence or presence of rat C/EBPI. In
addition, we also tested a modified form of NF-KB p65,
NF-KB p65mLZ, containing a point mutation in a recently
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TABLE 1. Inhibition of NF-KB Rel transcription
factors by C/EBPP'
Inhibition by rat C/EBPP
Transcription (% of induced level) with:
factor 4 pg of 6 pg of
vector vector
NF-KB p65 29.4 ± 6.1 18.6 ± 3.5
NF-KB p65mLZ 37.5 ± 3.2 25.5 ± 6.3
NF-KB p50 91.3 ± 27.8 65.2 ± 1.2
v-Rel 58.4 ± 20.3 40.5 ± 18.6
a Mouse F9 embryonal carcinoma cells were transiently cotransfected with
8 ,ug of KB-TATA-CAT (containing one copy of the KB enhancer from the
HIV-1 long terminal repeat [positions -105 to -79] linked to the TATA box
of the X laevis albumin gene), different amounts of expression vectors for
NF-KB p65, NF-KB p65mLZ, NF-KB p5O, and v-Rel, and different amounts (0,
4, and 6 pg) of the pCMV4T-rC/EBP,B expression vector. The total amount of
transfected DNA was kept constant by the addition of the parental pCMV4T
vector. At 6 h after transfection, CAT activity was determined. The mean
levels of CAT activity and standard errors determined in at least three
independent experiments are presented as percent inhibition relative to 100%
activity obtained with transfected pCMV4T alone.
described leucine zipper-like structure (73). For comparison
of the effects of rat C/EBPP on KB enhancer-dependent gene
expression, the amounts of transfected expression vectors
for NF-KB proteins were adjusted to obtain similar levels of
induced CAT activity. As shown in Table 1, rat C/EBP,
inhibited induction by NF-KB p65, NF-KB p65mLZ, and
v-Rel. The v-Rel oncoprotein functions as a KB-specific
transcriptional activator in the undifferentiated F9 cells used
for these transfection analyses (85). NF-KB p5O was a very
weak transcriptional activator, even when we transfected
large amounts of expression vector. This result and the
absence of endogenous NF-KB activity in F9 cells explains
why we obtained only weak inhibition of promoter activity
by rat C/EBPI when we used NF-KB p50.
Next, we were interested in whether these members of the
NF-KB/Rel family of transcription factors can synergistically
stimulate the SRE-TATA-CAT reporter in the presence of
rat C/EBPP. While transfecting a small amount of the rat
C/EBP,B expression plasmid with the control vector
pCMV4T yielded about 20-fold stimulation of CAT activity,
cotransfection of NF-KB p65, NF-KB p65mLZ, NF-KB p50,
v-Rel, or human c-Rel resulted in 3- to 7-fold higher levels of
gene expression (Table 2). Interestingly, NF-KB p65A10, a
naturally occurring variant of NF-KB p65 that has an internal
10-amino-acid deletion and that can dimerize only very
weakly (61, 78a), and NF-KB p65Eco, a C-terminal trunca-
tion encompassing only the Rel homology domain and not
the C-terminal transactivation domain, were not able to
efficiently act in synergy with rat C/EBP, (Table 2). Both
proteins were expressed at levels comparable to those of
NF-KB p65, as shown by Western blot analysis (data not
shown).
The synergistic stimulation of C/EBP is limited to mem-
bers of the NF-KB/Rel family. Several members of other
transcription factor families, such as c-Jun, c-Fos, CREB,
and Myb, were not able to synergistically stimulate the
SRE-TATA-CAT reporter in the presence of rat C/EBP,B
(Table 2). These transcription factors were expressed at
levels similar to that of NF-KB p65 (as shown by Western
blot analysis; data not shown) and were able to transactivate
promoter-CAT constructs with their cognate binding sites
(Table 3 and data not shown). The specificity of the cross-
coupling between NF-KB and C/EBP was further shown by
TABLE 2. Synergistic stimulation of C/EBP,B by NF-KB Rel
transcription factorsa
Transcription factor Fold activation byrat C/EBPf3
pCMV4T..................................... 20.4 ± 2.6
NF-KB p65 ..................................... 133.6 ± 26.4
NF-KB p65mLZ ..................................... 113.2 ± 26.8
NF-KB p65Al10 ...................... ............... 39.1 ± 10.1
NF-KB p65Eco ......... 11.1 ± 2.3
NF-KB p50 ..................................... 82.7 ± 12.8
v-Rel ..................................... 67.8 ± 11.1
hc-Rel ..................................... 70.0 ± 8.3
c-Jun ..................................... 30.7 ± 4.6
c-Fos..................................... 33.9 ± 7.5
CREB ..................................... 29.9 ± 8.5
Myb ..................................... 39.3 ± 3.5
a Mouse F9 embryonal carcinoma cells were transiently cotransfected with
8 ,ug of SRE-TATA-CAT (containing four copies of the SRE of the human
c-fos promoter [positions -320 to -299]), 1 ,ug of pCMV4T-rC/EBP,B, and 3
,ug ofpCMV4T or expression vectors for NF-KB p65, NF-KB p65mLZ, NF-KB
p65A10, NF-KB p65Eco, NF-KB p50, v-Rel, hc-Rel, c-Jun, c-Fos, CREB, and
Myb. The total amount of transfected DNA was kept constant by the addition
of the parental pCMV4T vector. At 6 h after transfection, CAT activity was
determined. The mean levels of CAT activity and standard errors determined
in at least three independent experiments are presented as the fold induction
relative to the activity obtained with transfected pCMV4T alone.
the lack of synergistic stimulation of the CRE-TK-CAT
reporter by NF-KB p65 in the presence of CREB and of the
Myb-TK-CAT reporter in the presence of Myb (Table 3).
Requirement of the Rel homology domain and the bZIP
region for alterations in the DNA binding of NF-cB and
C/EBP family members. Our in vivo experiments showed a
functional interplay between two transcription factor fami-
lies, NF-KB/Rel and C/EBP. This interplay resulted in the
synergistic stimulation of reporter plasmids with C/EBP
binding sites and in the inhibition of reporter plasmids with
KB enhancer motifs. Thus, these data raised the possibility
that NF-KB and C/EBP might physically interact to form a
novel transcription factor complex that exhibits decreased
DNA binding activity and/or transcriptional activity when
tested with KB enhancer motifs but displays increased DNA
TABLE 3. Specificity for C/EBP of synergistic activation
by NF-KB p65a
Expt (CAT reporter) Transcription factor Relative CAT activity
A (CRE-TK-CAT) pCMV4T 1.0
CREB 3.7 ± 1.4
NF-KB p65 1.6 ± 0.3
NF-KB p65 + CREB 1.7 ± 0.5
B (Myb-TK-CAT) Control 1.0
Myb 8.4 ± 2.5
NF-KB p65 1.1 ± 0.8
NF-KB p65 + Myb 8.6 ± 3.4
a Mouse F9 embryonal carcinoma cells were transiently cotransfected in
experiment A with 8 p,g of CRE-TK-CAT (containing one copy of the
fibronectin promoter CREB binding site [positions -174 to -162]), 2 ,ug of
pCMV4T-CREB, and/or 1 ,ug of pCMV4T-p65 and in experiment B with 8 ,g
of Myb-TK-CAT (containing five copies of a Myb binding site), 0.8 ,g of
RSV-Myb, and/or 1 pg of pCMV4T-p65. The total amount of transfected
DNA was kept constant by the addition of the corresponding parental vectors.
At 6 h after transfection, CAT activity was determined. The mean levels of
CAT activity and standard errors determined in at least three independent
experiments are presented as the fold induction relative to the activity
obtained with transfected pCMV4T alone.
MOL. CELL. BIOL.
CROSS-COUPLING OF NF-KB WITH C/EBP 3969
binding activity and/or transcriptional activity when tested
with C/EBP binding sites. We expressed NF-KB p65 and
NF-KB p65mLZ in bacteria by using the FLAG-HMK ex-
pression vector system (15). This system produces fusion
proteins with two additional elements at the N terminus. The
first element is an 8-amino-acid antigenic epitope recognized
by the M2 anti-FLAG antibody. The second element is a
5-amino-acid recognition site for HMK. These elements
allow for the purification of the expressed proteins over an
M2 anti-FLAG antibody affinity column and for labeling in
vitro with [y-32P]ATP. Partially purified bacterial NF-KB p65
and NF-KB p65mLZ are composed of two major species,
full-length p65 and p65mLZ, respectively, and an -46-kDa
truncated protein (a degradation product or an internal
translation stop). We identified this 46-kDa protein as a
C-terminally truncated protein because it can be labeled with
[y-32P]ATP, indicating the presence of the N-terminal HMK
peptide, and by use of antibodies directed against an N-ter-
minal or a C-terminal peptide of NF-,B p65 (data not
shown).
We were interested in whether NF-iB p65 is able to
change the binding of C/EBP to its cognate binding site.
EMSA were performed with bacterially expressed and par-
tially purified human C/EBP. The binding of full-length
C/EBP3 and the bZIP regions of C/EBPa, C/EBPI, and
C/EBPb to a C/EBP binding site was strongly enhanced by
the addition of bacterially expressed NF-KB p65 (Fig. 3),
although no change in the mobility of the DNA-protein
complex was observed (see Discussion). The amount of
added bacterial protein was kept constant by the addition of
a bacterial extract expressing only the FLAG-HMK peptide.
NF-K.B p65 was not able to bind to a C/EBP binding site by
itself but bound to a rB binding site (data not shown). The
increase in DNA binding activity might have depended on
the basic DNA binding region of NF-iB p65, since basic
polypeptides, such aspoly-L-lysine, also enhanced C/EBP
DNA binding activity (10) (data not shown) (see Discussion).
Furthermore, the addition of increasing amounts of bac-
terially expressed, partially purified rat FLAG-HMK-
C/EBP,B inhibited the DNA binding of bacterially expressed
NF-KB p65 and NF-KB p65mLZ as well as NF-KB p65 and
NF-KB p50 expressed in vivo in COS cells (data not shown).
Of note, we were unable to detect any effects of bacterially
expressed human C/EBPP on the DNA binding of NF-KB
p65 (see Discussion).
In vitro association of the Rel homology domain of NF-KB
with the bZIP region of C/EBP3. Studies were performed to
determine whether NF-KB and C/EBPI can associate in
vitro in the absence of DNA. For these studies, NF-KB p65,
NF-KB p65mLZ, and NF-KB p50 were expressed in bacteria
by use of the FLAG-HMK expression vector system, par-
tially purified, and labeled in vitro with [y_32p]ATp. The
radioactively labeled NF-KB p65 and NF-KB p65mLZ pro-
teins were separately combined with bacterially expressed
NF-KB p50, rat C/EBP,B , human C/EBPPbZIP, or bacterially
expressed FLAG-HMK peptide. The potentially formed
heteromeric protein complexes were chemically cross-linked
by use of the reversible cross-linker DSP to stabilize the
complexes during immunoprecipitation. Before the samples
were subjected to SDS-PAGE, the cross-linked complexes
were cleaved under reducing conditions. The full-length and
C-terminally truncated 32p-labeled NF-KB p65 proteins (see
above) were efficiently coimmunoprecipitated with anti-p5O
antibodies through their association with NF-KB p50 (Fig. 4,
compare lanes 1 and 2). Similarly, both forms of 32p-labeled
NF-KB p65 protein were coimmunoprecipitated with anti-
C/EBPP C/EBPPbZIP C/EBPabZIP C/EBP6bZIP CIEBPPbZ1P
1 2 3 4 5 6 7 8 9 10 11 12 13 14
FIG. 3. NF-KB stimulates DNA binding of C/EBP proteins. Bac-
terially expressed, purified human C/EBP,B or human C/EBPIbZIP,
C/EBPabZIP, and C/EBP8bZIP (truncated proteins that contain
only the DNA binding region and leucine zipper) were incubated
with increasing amounts (0, 1, and 5 pl) of bacterially expressed,
partially purified FLAG-HMK-NF-KB p65 or affinity-purified
NF-KB prepared from the cytosol of HeLa cells (5p,l) for 15 min at
RT in EMSA buffer with 0.1 pg of poly(dI-dC) and 5pLg of bovine
serum albumin. After the addition of a2P-labeled probe (C/EBP)
and incubation at RT for 30 min, DNA-protein complexes were
analyzed by EMSA with 0.25 x Tris-borate-EDTA native gels. All
shifted DNA-protein complexes were shown to be specific by
competition with an unlabeled oligonucleotide (data not shown).
C/EBP3 antibodies in the presence of full-length C/EBPP
(Fig. 4, compare lanes 3 and 4). To determine which portion
of C/EBPP associated with NF-KB p65, we combined32p-
NF-KB p65mLZ with full-length rat C/EBP,B and the trun-
cated form of human C/EBP,BbZIP. Both proteins interacted
with NF-KB p65, as shown by coimmunoprecipitations with
antibodies directed against a C-terminal peptide of human
C/EBPI (Fig. 4, lanes 6 to 9). Likewise, we showed an
interaction between NF-KB p50 and rat C/EBPP (Fig. 4,
lanes 10 and 11).
We also used an alternative approach to show an interac-
tion between NF-KB and C/EBP,B. The coding regions of ratC/EBP,B or an N-terminal truncation of rat CIEBPI encoding
only the bZIP region (CIEBP,bZIP) were fused in frame to
the GST gene. GST fusion proteins were expressed in
bacteria and bound to glutathione-Sepharose 4B beads.
Wild-type NF-KB p65 and NF-KB p50 and several mutant
cDNAs of NF-KB p65 were transcribed in vitro and trans-
lated in a rabbit reticulocyte lysate in the presence of[[35Smethionine or[35S]cysteine. All radiolabeled proteins
were expressed at similar levels (data not shown). The
radiolabeled proteins were incubated separately with control
GST beads, GST-C/EBP,B beads, or GST-C/EBPIbZIP
beads. After being extensively washed, the bound proteins
were eluted and analyzed by SDS-PAGE. The radiolabeled
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anti-p65 0
anti-C/EBPI- * * * 0 * * * O
anti-p50 0 0 0
32P-FLAG-p5O S .
32P-FLAG-p65mLZ S S S 0
32P-FLAG-p65 0 * 0 0 0
C/EBPPbZIP 0
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FIG. 4. In vitro association of NF-KB with C/EBPP. Bacterially
expressed, purified proteins were incubated as indicated with 32p_
labeled bacterial NF-KB p65 (lanes 1 to 5), NF-KB p65mLZ (lanes 6
to 9), and NF-KB p50 (lanes 10 to 12). After being cross-linked with
DSP, the protein complexes were immunoprecipitated with antibod-
ies directed against NF-KB p50 (lanes 1, 2, and 12), anti-C/EBPP
(lanes 3, 4, and 6 to 11), and antibodies directed against NF-KB p65
(lane 5). The immunocomplexes were reduced and subjected to
SDS-PAGE. The arrowheads indicate the positions of the 32P-
labeled proteins. Numbers to the left of the gel are in kilodaltons.
proteins bound only weakly or not at all to the control GST
beads (Fig. 5A, lanes 2 to 5). As expected, full-length NF-KB
p65 and a C-terminal truncation of NF-KB p65 encompassing
only the Rel homology domain (NF-KB p65Eco) bound
efficiently to GST-C/EBPO (Fig. 5A, lanes 6 and 8) or to
GST-C/EBP,BbZIP (Fig. 5A, lanes 10 and 11). A shorter
truncation of NF-KB p65 encompassing only a portion of the
Rel homology domain (NF-KB p65Bgl) was unable to bind to
GST-C/EBPI (Fig. SA, lane 9) or to GST-C/EBPIbZIP (Fig.
5A, lane 12). These results identify the cross-coupling of
C/EBP,B with NF-KB as a bZIP-Rel homology domain inter-
action. The alternatively spliced form of NF-KB p65 (NF-KB
p65A10), which had only weak effects on C/EBP,B transacti-
vation in vivo (Table 2), was not able to efficiently interact
with C/EBPI in vitro (Fig. 5A, lane 7). We also demon-
strated the physical association of NF-KB p50 with GST-C/
EBP,B and GST-C/EBPPbZIP (data not shown).
The observed physical interaction between NF-KB p65
and C/EBP,B indicates it to be of an affinity similar to that of
the homodimer formation between 35S-radiolabeled NF-KB
p65 and GST-NF-KB p65 beads (compare Fig. SA, lanes 6
and 8, with Fig. SB, lanes 4 and 5). The specificity of this
interaction was further proven by mixing 5S-radiolabeled
NF-KB p65Eco and c-Fos proteins and applying this mixture
to GST-C/EBPPI beads. As expected, NF-KB p65Eco bound
specifically to GST-C/EBP,B and GST-C/EBP,BbZIP (Fig.
5C, lanes 3 to 5), while c-Fos, in accordance with our in vivo
data (Table 2), did not specifically interact with C/EBPI.
DISCUSSION
In this report, we demonstrate the functional and physical
associations of members of two important transcription
factor families, NF-KB and C/EBP. The functional associa-
tions are characterized by (i) the inhibition of NF-KB-
induced expression of promoters containing NF-KB binding
sites by the expression of C/EBP family members and (ii) the
positive synergistic action of NF-KB family members with
C/EBP family members on promoters containing C/EBP
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FIG. 5. The Rel homology domain of NF-KB interacts with the
bZIP region of C/EBP,B in vitro. (A) Radiolabeled, rabbit reticulo-
cyte lysate-translated proteins (5 ,ul) were incubated as indicated
with bacterially expressed GST (lanes 2 to 5), GST-C/EBPI (lanes 6
to 9), and GST-C/EBPPbZIP (lanes 10 to 12) immobilized on
glutathione-Sepharose 4B beads. (B) Radiolabeled NF-KB p65 or
NF-KB p65Eco (5 ,ul) was incubated separately with control GST
beads (lanes 2 and 3) or GST-NF-KB p65 beads (lanes 4 and 5). (C)
Radiolabeled c-Fos and NF-KB p65Eco (5 pA each) were mixed and
incubated with control GST beads, GST-C/EBPI beads, or GST-C/
EBP1bZIP beads. Lanes 1 and 2 show one-fifth of the input amounts
used for lanes 3 to 5. After being extensively washed, the bound
proteins were eluted and analyzed by SDS-PAGE. Equal amounts of
bacterially expressed fusion proteins were bound to glutathione-
Sepharose 4B beads. All radiolabeled proteins were expressed in the
rabbit reticulocyte lysate at similar levels (data not shown). Num-
bers to the left of the gels are in kilodaltons.
strongly act in synergy with members of the C/EBP family of
transcription factors in regulating gene expression mediated
by the multimerized c-fos SRE. In addition, we demonstrate
a physical interaction between the two transcription factor
families through contacts on the Rel homology domain of
NF-KB and on the bZIP region of C/EBP. The experiments
that revealed that several functional NF-KB subunits (p50,
p65, and c-Rel) interact with three different isoforms of
C/EBP (a, 1, and b) indicated a general interaction between
these families and not merely a limited interaction between
individual members. Interestingly, and supporting our data,
the work of LeClair et al. (50) demonstrated that screening of
a Xgtll expression library with radiolabeled NF-KB p50
identified a cDNA encoding C/EBP3. The functional syn-
ergy was limited to members of the NF-KB and C/EBP
families, since other transcription factors, such as c-Jun,
c-Fos, CREB, and Myb, were not able to act in synergy with
C/EBP and NF-KB p65 did not act in synergy with CREB
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and Myb (Tables 2 and 3). Our data also suggest an inhibition
of CREB-induced promoter activity by NF-KB p65.
The positive synergy observed between the NF-KB and
C/EBP families of transcription factors in regulating gene
expression (Fig. 1B and C, Fig. 2B, and Table 2) presumably
is based on the direct physical interaction between these
factors. We found that NF-KB p65 increases the formation of
complexes between C/EBP and its DNA binding site (Fig. 3).
It was of interest that the mobility of the C/EBP-DNA
complexes was not altered by the addition of NF-KB p65,
suggesting that NF-KB p65 is not part of the complexes
detected by EMSA. Thus, it is possible that NF-KB p65
functions to stabilize the C/EBP-DNA interaction by form-
ing a ternary complex in solution but that any NF-KB p65
associated with this complex becomes separated during
electrophoresis. A similar observation was reported recently
for the interaction between the homeodomain protein Phoxl
and the serum response factor (36). Another possibility is
that NF-KB p65 transiently interacts with CIEBP and causes
a conformational change in C/EBP that then results in
increased DNA binding of C/EBP accompanied by the
release of NF-KB p65 from the complex. A similar mecha-
nism has been postulated for the increase in MyoDl DNA
binding by HSP90 (75). Furthermore, it has been shown that
C/EBP DNA binding is also increased by small basic poly-
peptides, such as poly-L-lysine (10). Therefore, the increase
in C/EBP DNA binding by NF-KB p65 might depend on the
basic DNA binding region of NF-KB p65. Experiments with
a truncated form of NF-KB missing the C-terminal transac-
tivation domain (NF-KB p65Eco; Table 2) indicated that the
functional synergy in vivo not only was a result of increased
DNA binding of the C/EBP-NF-KB p65 complex but also
depended on the transactivation domain of NF-KB p65.
Our experiments clearly demonstrate the direct physical
association between NF-KB and C/EBP through an interac-
tion of the Rel homology domain and the bZIP region (Fig. 4
and 5). This interaction is detected in the absence of binding
site DNA. A truncated form of NF-KB p65 expressing only
the Rel homology domain (NF-KB p65Eco) efficiently asso-
ciates with a truncated form of C/EBPP expressing only the
bZIP region (C/EBPIbZIP) (Fig. SA). Further deletion of the
NF-KB p65 Rel homology region (NF-KB p65Bgl) or an
internal deletion of 10 amino acids within the Rel homology
region (NF-KB p65A10) results in a loss of the interaction
with C/EBPI (Fig. SA). This result leads to the conclusion
that the same motifs that play a role in dimer formation
within the NF-KB and C/EBP families of transcription fac-
tors are also used for complex formation between the C/EBP
and NF-KB families. Alternatively, since these mutations in
the Rel homology domain also prevent homodimer formation
by NF-KB p65, it is possible that a monomeric form of
NF-KB p65 does not interact with C/EBP,B. Chimeric pro-
teins containing the GAL4 DNA binding and dimerization
domain (amino acids 1 to 147) fused in frame to NF-KB
p65Eco or NF-KB p65Bgl are able to form homodimers
through the GALA domain, but only GAL4-NF-KB p65Eco
is able to interact with C/EBP (data not shown). This result
suggests either that amino acids 195 to 282 of NF-KB p65,
missing in GALA NF-KB p65Bgl, are the target for the
physical interaction between these two families or that
deletion of the C-terminal portion of the Rel homology
domain changes the conformation of the residual protein,
preventing an interaction with C/EBP.
If NF-KB and C/EBP physically interact in vitro and
synergistically activate promoters in vivo, then they may
also physically interact in vivo. We have not detected an in
vivo interaction, probably because of the very low intracel-
lular concentrations of NF-KB and C/EBP family members.
Furthermore, the interaction appears to be stabilized by
binding site DNA (see below). The specificity of the physical
interaction between NF-KB and C/EBP is also evident from
our protein mixing experiments proving that c-Fos, which
does not cross-couple with C/EBP, is not able to bind to
GST-C/EBPI beads (Fig. SC) and from experiments showing
that NF-KB p65 binds with similar affinities to GST-NF-KB
p65 beads and to GST-C/EBP,B beads (Fig. SB).
The basis for the inhibition of NF-KB transactivation of
gene expression by C/EBP (Fig. 1A, Fig. 2A, and Table 1) is
not known. One possibility is that C/EBP blocks the ability
of NF-KB to interact with a critical transcriptional cofactor.
This process is termed "squelching" and has been described
elsewhere (57, 68). If this hypothesis is true, it is curious why
squelching was not observed when a C/EBP-responsive
reporter plasmid was used in the presence of the two
transcription factors. A second explanation is the possible
induction of an inhibitor of NF-KB function by the expres-
sion of C/EBP in F9 cells. Although we cannot rule out these
mechanisms, we favor a third explanation: the formation
between C/EBP and NF-KB of a novel transcription factor
complex with reduced transcriptional activity at KB enhanc-
ers. The latter could be manifested by a reduced affinity for
KB binding sites or the inability of the complex to stimulate
transcriptional activity. We have observed that bacterially
expressed rat C/EBPP inhibits the ability of NF-KB p65 and
NF-KB p50 to bind to its cognate sequence, yet bacterially
expressed human C/EBPI does not alter the ability of
NF-KB to bind to DNA (data not shown). It is not clear
whether this result is caused by the presence of the N-ter-
minal FLAG-HMK region on the rat protein or whether it
reflects differences in the concentrations or state of purifi-
cation of these proteins. It is important to note that three
isoforms of human C/EBP (a, 1B, and b) are able, like rat
C/EBPP, to inhibit NF-KB-induced gene activation (Fig.
2A).
The nature of the molecular complex formed between
NF-KB and C/EBP is not clear, but evidence points to an
interaction between the diner forms of the two factors.
First, a mutation in a putative NF-KB p65 leucine zipper
does not block the functional or physical interaction between
this protein and C/EBP (Tables 1 and 2 and Fig. 4). In
addition, no leucine zipper-like structure has been reported
in NF-KB p50, v-Rel, or c-Rel, yet these proteins function-
ally and physically interact with C/EBP family members
(Tables 1 and 2 and Fig. 4). Second, an alternatively spliced
form of NF-KB p65 (NF-KB p65A10) and a C-terminally
truncated form (NF-KB p65Bgl) that cannot efficiently dimer-
ize (61, 78a) do not functionally or physically interact with
C/EBP subunits (Table 2 and Fig. 5). This result suggests
that the same motif that is necessary for dimer formation is
also involved in cross-dimerization between these two fam-
ilies. Of particular importance is the observation that a single
C/EBP binding site is sufficient to function as a target for the
functional synergy between NF-KB and C/EBP (Fig. 1C).
Thus, it is unlikely that NF-KB makes DNA contacts on the
single C/EBP binding site. This idea supports the model of a
dimer of a C/EBP family member binding to DNA and
interacting through its bZIP region with the Rel homology
region of an NF-KB family member. Presumably, an altered
configuration of the transcription factor complex is stabilized
and ultimately is more efficient in interacting with the basic
transcriptional machinery.
What is the functional significance of the interactions
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observed between NF-KB and C/EBP? Of particular interest
is the observation that NF-KB can augment gene expression
mediated through the multimerized c-fos SRE in the pres-
ence of C/EBP. Thus, NF-KB subunits, which are strongly
implicated in the control of cellular proliferation and are
induced in the Go-to-G1 transition (7), may functionally
stimulate c-fos gene expression when C/EBP is present.
C/EBP is induced by compounds that activate cAMP (55),
and evidence has been presented that increased cAMP levels
may induce preexisting NF-KB as well (76, 77). Thus, an
increase in cAMP levels may coinduce C/EBP and NF-KB,
allowing for enhanced expression from C/EBP binding sites
and, potentially, a decrease in gene expression mediated by
NF-KB binding sites. A basis for the functional interaction of
NF-KB and C/EBP is also supported by studies with IL-1 and
IL-6. IL-1 is known to induce NF-KB (64), and IL-6 activates
C/EBPP (66). The physical and functional interactions ob-
served between NF-KB and C/EBPI may explain the func-
tional synergy observed between IL-1 and IL-6 in several
physiological responses, including the acute-phase response,
in T-cell activation, and in immunoglobulin secretion (1, 37,
83). In this regard, the IL-6 promoter contains both an
NF-KB binding site and a C/EBP binding site (37, 40, 52).
Both sites have been shown to be targets for IL-1 and tumor
necrosis factor alpha stimulation (37); thus, it is likely that
the induction of NF-KB by IL-1 and tumor necrosis factor
alpha functions to stimulate gene expression from each site.
Furthermore, the IL-8 promoter contains adjacent binding
sites for C/EBP and NF-KB that cooperate in gene activation
(58), and the angiotensinogen promoter contains overlapping
binding sites for these two transcription factors (19). Prelim-
inary data obtained with the IL-8 promoter show coopera-
tive binding of NF-KB and C/EBP to their adjacent binding
sites, resulting in a dose-dependent synergistic activation of
the IL-8 promoter (78a). Functional interactions between
C/EBP and NF-KB subunits could have profound influences
on cellular growth control. It has been demonstrated that
C/EBPa is growth inhibitory and likely functions in the
terminal differentiation of certain cells (27, 82). The expres-
sion of C/EBP isoforms could alter the ability of NF-KB
subunits to control cellular proliferation.
There is growing evidence that the regulation of gene
expression is not mediated solely by the presence or absence
of a particular set of transcription factors. The function of a
transcription factor can be inhibited by the presence of a
specific inhibitor that blocks the ability of the transcription
factor to bind to DNA (6). In addition, the interplay of
transcription factors themselves likely functions as a critical
regulatory component of gene expression. Physical and
functional interactions, usually dimerization, of factors
within a particular family are well documented. However,
recent reports indicate cross-family interactions of specific
transcription factors. One example is the interaction be-
tween the glucocorticoid receptor and the AP-1 proteins Fos
and Jun (24, 42, 53, 74, 87). A second example is the recent
report of the interaction between the leucine zipper protein
Jun and the helix-loop-helix protein MyoD (12). Our data
demonstrate that the important transcription factor families
C/EBP and NF-KB functionally and physically interact. This
observation, along with those made previously, highlights a
unique mechanism by which the levels of one transcription
factor can strongly modulate the functional activity of an-
other.
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ADDENDUM IN PROOF
The plasmids described as encoding human C/EBP forms
as well as the recombinant proteins encoded by their respec-
tive cDNAs were erroneously named and are actually rat
(C/EBPa) or mouse (C/EBP, and C/EBP8). This does not
alter the interpretations of any of the data.
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